Global University Venturing

Contrary Capital is seeding a second vehicle to back spinouts and university-linked startups through venture partners based at faculties across the US.

Fraunhofer has invested in Enerthing, which is launching IoT products powered by solar foils invented in partnership with Fraunhofer ISE.

GV participated as a new investor, as Harvard's genetic medicine developer Beam Therapeutics completed a round that followed $87m in series A funding last year.

ETH’s Paul Scherrer Institute has launched Araris Biotech to deliver production technology for site-specific ADCs that enable them to be used without being engineered from each patient.

Satt Sud-Est spinouts Click4Tag, C4Hydro and C4Biocontrol will merge to boost the commercialisation of microbe monitoring technologies built on research from six institutions.

University of Tokyo’s Utec has extended its foray into Indian VC investments by starting an accelerator in partnership with local venture fund Blume Ventures.

Oxford-founded biopharmaceutical development instrument manufacturer Refeyn has secured funding from the university and OSI to help scale manufacturing and distribution.

Vilmorin & Cie has joined fellow corporates including BNP Paribas, Naval Group and MGEN as an investor in the targeted $87.5m PSL Innovation Fund.

Zurich brain injury antibody spinout NovaGo has extended its strategic partnership with immunotherapy company Neurimmune by securing its support in a series A round.

Building on early development funding from TAU’s Technology Innovation Momentum Fund, Trobix Bio has spun out to commercialise an approach to overcoming antibacterial resistance.

Kao Yuan University's Gintel has created water quality monitoring systems that can provide information on 50 parameters of toxicity and recommend remedies.